NCT00356720View on ClinicalTrials.gov

Efficacy and Safety of 2 Dosing Regimens of T1225 Eye Drops 1.5% Versus Oral Azithromycin in Treatment of Trachoma

PHASE3CompletedINTERVENTIONAL

Timeline

Start Date

January 31, 2004

Study Completion Date

May 31, 2004

Conditions

Trachoma

Interventions

DRUG

Azithromycin

Sponsors

Lead Sponsor

Laboratoires Thea

All Listed Sponsors

lead

Laboratoires Thea

INDUSTRY